Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
- PMID: 33559346
- PMCID: PMC8006684
- DOI: 10.1002/ehf2.13257
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Abstract
Aims: Congestive heart failure (CHF) and impaired renal function are two often co-existing medical conditions and associated with adverse cardiovascular outcome. The aim of the current study was to assess renal and intraglomerular haemodynamics by constant infusion input clearance technique in subjects with CHF.
Methods and results: The group of subjects with CHF consisted of 27 individuals with HFpEF and 27 individuals with HFrEF and were compared with 31 healthy controls. Subjects underwent renal clearance examination to measure glomerular filtration rate (GFR) and renal blood and plasma flow (RBF and RPF) and to calculate intraglomerular haemodynamics such as resistances of the afferent (RA ) and efferent arterioles (RE ) as well as intraglomerular pressure (Pglom ). Measured GFR was lower in CHF subjects (68.1 ± 10.1 mL/min/1.73 m2 ) compared with controls (83.6 ± 13.4 mL/min/1.73 m2 , Padj < 0.001) as was Pglom (Padj < 0.001). Total renal vascular resistance (RVR) was higher in CHF subjects (87.3 ± 20.1 vs. 73.8 ± 17.1 dyn × s/cm5 , Padj < 0.001) mediated by an increased resistance at the afferent site (3201 ± 1084 vs. 2181 ± 796 dyn × s/cm5 , Padj < 0.001). Comparing HFpEF and HFrEF subjects, RA was higher in HFrEF subjects. The severity of CHF assessed by NT-proBNP revealed an inverse association with renal perfusion (RPF r = -0.421, P = 0.002, RBF r = -0.414, P = 0.002) and a positive relation with RVR (r = 0.346, P = 0.012) at the post-glomerular site (RE : r = 0.318, P = 0.022).
Conclusions: Renal function assessed by measured GFR is reduced and renal vascular resistance at the preglomerular, afferent site is increased in HFpEF and, to greater extent, in HFrEF. Our data indicate a close cardiorenal interaction in CHF.
Trial registration: ClinicalTrials.gov NCT03672591.
Keywords: Cardiorenal interaction; Heart failure; Preserved ejection fraction; Reduced ejection fraction; Renal haemodynamics.
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
Conflict of interest statement
R. E. S. has received speaker fees and advisory board fees from Novartis Pharma GmbH, Germany, during the conduct of the study. The other authors declare that they have no competing interests.
Figures
Similar articles
-
Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function.Drugs. 1990;39 Suppl 4:10-21; discussion 22-4. doi: 10.2165/00003495-199000394-00004. Drugs. 1990. PMID: 2354670
-
Relation of Renal Function with Left Ventricular Systolic Function and NT-proBNP Level and Its Prognostic Implication in Heart Failure with Preserved versus Reduced Ejection Fraction: an analysis from the Korean Heart Failure (KorHF) Registry.Korean Circ J. 2017 Sep;47(5):727-741. doi: 10.4070/kcj.2017.0050. Epub 2017 Aug 16. Korean Circ J. 2017. PMID: 28955391 Free PMC article.
-
Relation between waist circumference and the renal hemodynamic in healthy individuals.Nutr Metab Cardiovasc Dis. 2024 Mar;34(3):755-762. doi: 10.1016/j.numecd.2023.10.033. Epub 2023 Nov 4. Nutr Metab Cardiovasc Dis. 2024. PMID: 38000996 Clinical Trial.
-
Renin-Angiotensin System Inhibition, Worsening Renal Function, and Outcome in Heart Failure Patients With Reduced and Preserved Ejection Fraction: A Meta-Analysis of Published Study Data.Circ Heart Fail. 2017 Feb;10(2):e003588. doi: 10.1161/CIRCHEARTFAILURE.116.003588. Circ Heart Fail. 2017. PMID: 28209765 Review.
-
Renal Dysfunction and Heart Failure with Preserved Ejection Fraction.Heart Fail Clin. 2021 Jul;17(3):357-367. doi: 10.1016/j.hfc.2021.03.005. Heart Fail Clin. 2021. PMID: 34051968 Review.
Cited by
-
Advances in extracardiac mechanisms for heart failure with preserved ejection fraction.Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Dec 28;47(12):1733-1739. doi: 10.11817/j.issn.1672-7347.2022.220310. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022. PMID: 36748385 Free PMC article. Chinese, English.
-
Association of Angiotensin Receptor-Neprilysin Inhibitors Use and Better Cardiorenal Outcomes in Patients With Heart Failure and Acute Kidney Disease.Cardiovasc Drugs Ther. 2025 Apr 23. doi: 10.1007/s10557-025-07698-x. Online ahead of print. Cardiovasc Drugs Ther. 2025. PMID: 40266448
-
Cardiorenal Interorgan Assessment via a Novel Clustering Method Using Dynamic Time Warping on Electrocardiogram: Model Development and Validation Study.JMIR Med Inform. 2025 Aug 12;13:e73353. doi: 10.2196/73353. JMIR Med Inform. 2025. PMID: 40795375 Free PMC article.
-
Extracorporeal organ support and the kidney.Front Nephrol. 2022 Aug 5;2:924363. doi: 10.3389/fneph.2022.924363. eCollection 2022. Front Nephrol. 2022. PMID: 37674997 Free PMC article. Review.
-
Diagnostic potential of energy metabolism-related genes in heart failure with preserved ejection fraction.Front Endocrinol (Lausanne). 2023 Nov 27;14:1296547. doi: 10.3389/fendo.2023.1296547. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38089628 Free PMC article.
References
-
- Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 1993; 22: 6A–13A. - PubMed
-
- Tonelli M, Riella MC. Chronic kidney disease and the aging population. Kidney Int 2014; 85: 487–491. - PubMed
-
- Filippatos G, Farmakis D, Parissis J. Renal dysfunction and heart failure: things are seldom what they seem. Eur Heart J 2014; 35: 416–418. - PubMed
-
- Damman K, Valente MA, Voors AA, O'Connor CM, van Veldhuisen DJ, Hillege HL. Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta‐analysis. Eur Heart J 2014; 35: 455–469. - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials